Prasad V - Search Results

1

A novel framework to assess haematology and oncology registration trials: The THEOREMM project.

Olivier T, Haslam A, Burke P, Boutron I, Naudet F, Ioannidis JPA, Prasad V. Olivier T, et al. Among authors: prasad v. Eur J Clin Invest. 2024 Oct;54(10):e14267. doi: 10.1111/eci.14267. Epub 2024 Jun 27. Eur J Clin Invest. 2024. PMID: 38934596 Free article. Review.

2

Reversals of established medical practices: evidence to abandon ship.

Prasad V, Cifu A, Ioannidis JP. Prasad V, et al. JAMA. 2012 Jan 4;307(1):37-8. doi: 10.1001/jama.2011.1960. JAMA. 2012. PMID: 22215160 No abstract available.

3

Observational studies often make clinical practice recommendations: an empirical evaluation of authors' attitudes.

Prasad V, Jorgenson J, Ioannidis JP, Cifu A. Prasad V, et al. J Clin Epidemiol. 2013 Apr;66(4):361-366.e4. doi: 10.1016/j.jclinepi.2012.11.005. Epub 2013 Feb 4. J Clin Epidemiol. 2013. PMID: 23384591 Review.

4

Evaluating health system processes with randomized controlled trials.

Ioannidis JP, Prasad V. Ioannidis JP, et al. Among authors: prasad v. JAMA Intern Med. 2013 Jul 22;173(14):1279-80. doi: 10.1001/jamainternmed.2013.1044. JAMA Intern Med. 2013. PMID: 23689271 No abstract available.

5

Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices.

Prasad V, Ioannidis JP. Prasad V, et al. Implement Sci. 2014 Jan 8;9:1. doi: 10.1186/1748-5908-9-1. Implement Sci. 2014. PMID: 24398253 Free PMC article.

6

When is crossover desirable in cancer drug trials and when is it problematic?

Haslam A, Prasad V. Haslam A, et al. Among authors: prasad v. Ann Oncol. 2018 May 1;29(5):1079-1081. doi: 10.1093/annonc/mdy116. Ann Oncol. 2018. PMID: 29648572 Free PMC article. No abstract available.

7

Multivitamins Do Not Reduce Cardiovascular Disease and Mortality and Should Not Be Taken for This Purpose: How Do We Know That?

Haslam A, Prasad V. Haslam A, et al. Among authors: prasad v. Circ Cardiovasc Qual Outcomes. 2018 Jul;11(7):e004886. doi: 10.1161/CIRCOUTCOMES.118.004886. Circ Cardiovasc Qual Outcomes. 2018. PMID: 29991647 Free article. No abstract available.

8

A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology.

Haslam A, Hey SP, Gill J, Prasad V. Haslam A, et al. Among authors: prasad v. Eur J Cancer. 2019 Jan;106:196-211. doi: 10.1016/j.ejca.2018.11.012. Epub 2018 Dec 5. Eur J Cancer. 2019. PMID: 30528804 Free article.

9

Where Does the Blame for High Health Care Costs Go? An Empirical Analysis of Newspaper and Journal Articles Criticizing Health Care Costs.

Haslam A, Crain T, Gill J, Herrera-Perez D, Prasad V. Haslam A, et al. Among authors: prasad v. Am J Med. 2019 Jun;132(6):718-721. doi: 10.1016/j.amjmed.2018.12.019. Epub 2019 Jan 9. Am J Med. 2019. PMID: 30639552 Free article.

10

Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs.

Haslam A, Prasad V. Haslam A, et al. Among authors: prasad v. JAMA Netw Open. 2019 May 3;2(5):e192535. doi: 10.1001/jamanetworkopen.2019.2535. JAMA Netw Open. 2019. PMID: 31050774 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,046 results

Search Page

Filters